Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-24-023416 General Corporate
Debt relative to revenue 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
27.87% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.84% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.76% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
0.68% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
96.30% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
26.90% · CORE · VALID
Operating margin 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
9.11% · CORE · VALID
R&D intensity 20th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.65% · OPTIONAL · VALID
SBC intensity 33th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.37% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 59.96%
Current 27.87%
Delta -32.09% Capex Intensity Decreased
Previous 0.89%
Current 0.84%
Delta -0.05% Cash Generation Increased
Previous -0.19%
Current 20.76%
Delta 20.96% Growth Decreased
Previous 31.37%
Current 0.68%
Delta -30.69% Inventory Pressure Decreased
Previous 104.52%
Current 96.30%
Delta -8.22% Margin Decreased
Previous 27.36%
Current 26.90%
Delta -0.46% Profitability Decreased
Previous 9.69%
Current 9.11%
Delta -0.58% R And D Intensity Increased
Previous 4.19%
Current 4.65%
Delta 0.46% Sbc Intensity Decreased
Previous 0.38%
Current 0.37%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.